Companies
Company Logo
Oneliner
Company Logo
Oneliner
Add Entity
snc-logo

Startup Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Watchlists
My Saved Searches
Following
Inbox
About Us
Glossary

snackbar-icon
title

Create new Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
Notifications Off
Public content (accessible by all Finder users)

Add to watchlist

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Already have an account? Login

    Verify your email

    We’ve sent a verification link to [email protected]
    Reset password
    Don't have an account? Sign up

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    Search Startups

    B2B, D/Pre-Funding, Tagged as ('cancer-therapy') Startups

    Filters
    Clear

    Search by tag (1)

    All of
    Any of
    None of

    Sector 

    Primary Sector 

    Target Customer 

    Core Technology 

    Funding Stage (2)

    Founded 

    Total Raised 

    Min
    Max

    Market Cap 

    Min
    Max

    Business Models (1)

    Product Stage 

    Employees 

    Location 

    Status 

    13 Startups 0 In the News 0 Recently Updated
    • Total Funding
      $146.5M
      Raised
      4
      Events
    • Private Funding
      $146.5M
      Raised
      4
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $0
      Raised
      0
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags

    There aren’t any companies that match your search
    you can try looking for something else.

    Hopec Pharma logo

    Hopec Pharma

    Immunotherapy Treatment for Bladder Cancer
    2023 B2B 1-10 Pre-Funding Undisclosed
    cancer
    cancer-therapy
    cancer-research
    immuno-theraphy
    pharmaceuticals
    immunotherapy
    bacteria
    ReadeRx Therapeutics logo

    ReadeRx Therapeutics

    RNA-based Cancer Therapeutics
    2023 B2B 1-10 Pre-Funding Undisclosed
    oncology
    pharmaceuticals
    cancer-therapy
    cancer
    Nanorobotics logo

    Nanorobotics

    Nanorobots for Targeting and Destroying Cancer Cells
    2019 B2B 1-10 Pre-Funding Undisclosed
    pharmaceuticals
    cancer-therapy
    oncology
    treatments
    targeted-therapy
    biotechnology
    cell-therapy
    nanotechnology
    ApoRx Biopharmaceuticals logo

    ApoRx Biopharmaceuticals

    Targeted Protein Degradation Drug Discovery
    2021 B2B 1-10 Pre-Funding Undisclosed
    oncology
    pharmaceuticals
    immunotherapy
    pharma-companies
    biotechnology
    drug-discovery
    drug-design
    biopharmaceutical
    cancer-therapy
    cancer
    Fore Biotherapeutics logo

    Fore Biotherapeutics

    Precision Oncology Treatments
    2011 B2B 11-50 D $153.5M
    personalization
    oncology
    cancer
    pharmaceuticals
    genomics
    targeted-therapy
    patients
    artificial-intelligence
    drug-discovery
    machine-learning
    therapeutics
    cancer-therapy
    Novitero logo

    Novitero

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Cancer Drugs to Bypass Resistance Mutations
    2014 B2B 1-10 Pre-Funding $0
    drug-design
    drug-discovery
    targeted-cancer-therapy
    cancer-therapy
    personalization
    pharma-companies
    bioinformatics
    Zion Medical logo

    Zion Medical

    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Destruction of Cells Infected with HIV or Cancer
    2014 B2B 1-10 Pre-Funding Undisclosed
    cancer-therapy
    oncology
    drug-discovery
    pharmaceuticals
    cancer
    pharma-companies

    Notifications settings

    Off
    Frequency:
    Select all

    Search Startups

    13 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $146.5M
      Raised
      4
      Events
    • Private Funding
      $146.5M
      Raised
      4
      Rounds
    • Public Offerings
      $0
      Raised
      0
      Offerings
    • M&A
      $0
      Raised
      0
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    There aren’t any companies that match your search
    you can try looking for something else.

    Hopec Pharma logo
    Raised
    Undisclosed
    Hopec Pharma
    Immunotherapy Treatment for Bladder Cancer
    Founded:2023
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    ReadeRx Therapeutics logo
    Raised
    Undisclosed
    ReadeRx Therapeutics
    RNA-based Cancer Therapeutics
    Founded:2023
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Nanorobotics logo
    Raised
    Undisclosed
    Nanorobotics
    Nanorobots for Targeting and Destroying Cancer Cells
    Founded:2019
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    ApoRx Biopharmaceuticals logo
    Raised
    Undisclosed
    ApoRx Biopharmaceuticals
    Targeted Protein Degradation Drug Discovery
    Founded:2021
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Fore Biotherapeutics logo
    Raised
    $153.5M
    Fore Biotherapeutics
    Precision Oncology Treatments
    Founded:2011
    Business Model:B2B
    Employees:11-50
    Funding Stage:D
    Novitero logo
    Raised
    $0
    Novitero
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Cancer Drugs to Bypass Resistance Mutations
    Founded:2014
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Zion Medical logo
    Raised
    Undisclosed
    Zion Medical
    Presumed Inactive
    ?
    Based on data collected from different sources by our team,
    there are indicators that suggest that this company is no longer active. However, this information may not be accurate. If you believe this information should be updated, please .
    For more details, you can read our .
    Destruction of Cells Infected with HIV or Cancer
    Founded:2014
    Business Model:B2B
    Employees:1-10
    Funding Stage:Pre-Funding
    Unlock financial data
    Finder is provided for free by the non-profit organization Startup Nation Central.
    • Get unlimited search results
    • Save to custom lists - Watchlists
    • Get notified with news and updates
    • Connect with people
    And much more...
    I already have access,
    I already have access,